We make entering the US healthcare market easy, efficient, and impactful.
Commercial clarity so you can navigate the complex US healthcare landscape to get to revenue and validation quicker.
US commercialization is where you win.
It’s also where the risk is.
The sales cycle is long, winding, and opaque: 6-18 months; filled with numerous stakeholders, some of whom with conflicting priorities; and packed with a maze of budget structures and a marathon of procurement processes.
Navigating Regulatory and Reimbursement just gets you a ticket into the game.
It doesn’t teach you the rules to the game or train you with the skills to play competitively.
And it certainly doesn’t illuminate how you’ll win.
The US healthcare market is demanding, complex, and highly competitive.
Different isn’t enough. Clinical validation isn’t enough. Interesting isn’t enough.
Your company can’t effectively forge ahead without understanding its impact on revenue, workflow, and patient outcomes. These three components are mission-critical in defining how you will add value that becomes worthy of Procurement’s prioritization and ultimately a business relationship.
Your product may solve a real clinical problem and have a strong patient impact outcomes, but not drive a meaningful financial impact within the different factions of budgets and Reimbursement.
It may simply be incongruent with most (but not all!) of the spectrum of business models within our healthcare systems.
Yet international healthtech companies can absolutely succeed in the US.
Commercial success in the US for an international company takes a different approach, with different requirements, than the traditional domestic pathways.
Many organizations assume international companies ought to simply understand the US healthcare systems, adapt, and proceed according to the same commercial process as domestic companies–but this is shortsighted.
Retrofitting domestic strategy to suit international companies simply costs them time, money, and frustration.
International companies have a different set of tools at their disposal than their domestic counterparts at the same stage. It’s critical to work with specialists who understand this very specific intersection of commercial development and investment from an international perspective.
The international advantage
We believe that our international collaborations with entrepreneurs, researchers, and leading institutions benefit everyone–and that these partnerships can be truly mutually beneficial.
Internationally scaling companies tend to have lower clinical and technical risk, a tremendous fortitude for navigating bureaucracies, and patient- and provider-centric perspectives that contribute to the Quadruple Aim.
What remains is commercial navigation, adapting models from Bismark and Beveridge, and phasing entry in a strategic manner that makes sense for tranched funding.
Given traditional differences in valuation, this means that US investors find lower-risk companies for the same check size–as long as they have a grounded market entry strategy and the right partners in place to execute.
Get current, real-world resources & insights
01. Apply to join the Healthtech Bridge program
12-week program designed specifically for international healthtech scaleups, get to US revenue and validation faster and more efficiently.
03. Deal scouting & market access pulse
Full portfolio support—from deal scouting on the US investment side to providing insights and opportunities to EU investors
02. Actual, actionable answers
Sometimes you just need real-world insights, clarity, and some straightforward advice on an upcoming decision—and it just can’t wait.
04. Pre-order “Flight Rules”
Get the book that shares how to keep your scaleup under control and flying in turbulent times. Written by veteran commercial leaders.
Contact us.
Cillum deserunt magna labore.
Laboris ut duis non esse ad eu qui exercitation aliqua cillum magna mollit sunt. Laboris cupidatat aliquip exercitation est consequat quis velit eu.
Laboris ut duis non esse ad eu qui exercitation aliqua cillum magna mollit sunt. Laboris cupidatat aliquip exercitation est consequat quis velit eu.
Branding, Packaging
Cillum deserunt magna labore.
Laboris ut duis non esse ad eu qui exercitation aliqua cillum magna mollit sunt. Laboris cupidatat aliquip exercitation est consequat quis velit eu.
Laboris ut duis non esse ad eu qui exercitation aliqua cillum magna mollit sunt. Laboris cupidatat aliquip exercitation est consequat quis velit eu.
